Genentech is laying off 103 employees at its South San Francisco headquarters, with the cuts taking effect July 29, 2026, as part of a broader restructuring of its Research and Early Development (gRED) group.
The layoffs are concentrated in gRED, including the shutdown of the physiological chemistry and infectious disease teams and staff reductions in other research units, affecting senior leaders and scientists.
These workforce reductions follow Genentech’s strategic reevaluation of its R&D pipeline and priorities, while the company continues to pursue major oncology collaborations, including a reported $490 million breast cancer partnership to advance its pipeline in a competitive market.
Sources:
Genentech to lay off veteran scientists as part of 103 job cuts - San ...
Genentech to cut 103 jobs at South San Francisco headquarters
Genentech will permanently lay off 103 workers at its South San ...
San Francisco Business Times' Post - LinkedIn
Biotech pioneer Genentech will cut 103 jobs in its latest round of ...
Genentech Lays Off 103 Workers — South San Francisco, CA WARN Notice July 2026
🌱 Patch AM: How will Genentech's 103 local layoffs affect South San Francisco?
Genentech cuts more than 100 jobs at Bay Area headquarters
Genentech Restructures gRED Leadership, Signals R&D Strategic Shift
Genentech plans to permanently lay off 103 workers at its South San ...